Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease

Choi, 1993, Small hepatocellular carcinomas and associated nodular lesions of the liver: pathology, pathogenesis, and imaging findings, AJR Am J Roentgenol, 160, 1177, 10.2214/ajr.160.6.8388618 Bruix, 2001, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1 Bruix, 2005, Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma, Hepatology, 42, 1208, 10.1002/hep.20933 Bruix, 2011, Management of hepatocellular carcinoma: an update, Hepatology, 53, 1020, 10.1002/hep.24199 Yoon, 2009, Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3cm in diameter: tumor size and cellular differentiation, AJR Am J Roentgenol, 193, W482, 10.2214/AJR.08.1818 Kudo, 2011, Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version, Dig Dis, 29, 339, 10.1159/000327577 Lee, 2011, Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease, AJR Am J Roentgenol, 197, W868, 10.2214/AJR.10.6237 Nasu, 2009, Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade, AJR Am J Roentgenol, 193, 438, 10.2214/AJR.08.1424 Xu, 2010, Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver, J Comput Assist Tomogr, 34, 506, 10.1097/RCT.0b013e3181da3671 Bartolozzi, 2007, Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media, Eur Radiol, 17, 2519, 10.1007/s00330-007-0602-5 Kim, 2009, Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma, AJR Am J Roentgenol, 192, 1675, 10.2214/AJR.08.1262 Efremidis, 2007, Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges, Eur Radiol, 17, 2969, 10.1007/s00330-007-0705-z Hayashi, 1999, Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium, AJR Am J Roentgenol, 172, 969, 10.2214/ajr.172.4.10587130 Kim, 2005, Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma, AJR Am J Roentgenol, 184, 1069, 10.2214/ajr.184.4.01841069 Narita, 2009, Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma, J Gastroenterol, 44, 793, 10.1007/s00535-009-0056-4 Chou, 2010, Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging, J Magn Reson Imaging, 32, 895, 10.1002/jmri.22316 Kim, 2011, Hypervascular hepatocellular carcinoma 1cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging, AJR Am J Roentgenol, 196, W758, 10.2214/AJR.10.4394 Wilson, 2007, Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI, AJR Am J Roentgenol, 189, W7, 10.2214/AJR.06.1060 Stern, 2000, Dynamic MR imaging of liver metastases with Gd-EOB-DTPA, Acta Radiol, 41, 255, 10.1080/028418500127345208 Yamashita, 1996, Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver, Radiology, 200, 79, 10.1148/radiology.200.1.8657948 Semelka, 1992, Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5T, Radiology, 184, 687, 10.1148/radiology.184.3.1324509 Asayama, 2008, Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic–pathologic correlation, AJR Am J Roentgenol, 190, W28, 10.2214/AJR.07.2117 Kim, 2009, SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings, Korean J Radiol, 10, 112, 10.3348/kjr.2009.10.2.112 Sakabe, 2004, Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma, Dig Surg, 21, 413, 10.1159/000082318 Heo, 2010, Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor, Korean J Radiol, 11, 295, 10.3348/kjr.2010.11.3.295 Nishie, 2011, Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma, Eur J Radiol, 80, e29, 10.1016/j.ejrad.2010.06.019 Cha, 2014, Assessing patients with hepatocellular carcinoma meeting the Milan criteria: is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT?, J Magn Reson Imaging, 39, 842, 10.1002/jmri.24237 Kogita, 2010, Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow, Eur Radiol, 20, 2405, 10.1007/s00330-010-1812-9 Kudo, 2010, The 2008 Okuda lecture: management of hepatocellular carcinoma: from surveillance to molecular targeted therapy, J Gastroenterol Hepatol, 25, 439, 10.1111/j.1440-1746.2009.06207.x